Bruno Pitard

Title: Bruno Pitard: Innovator in Cationic Transfection Agents

Introduction

Bruno Pitard is a notable inventor based in Sceaux, France. He has made significant contributions to the field of biotechnology, particularly in the development of cationic transfection agents. With a total of 3 patents to his name, his work has implications for gene therapy and molecular biology.

Latest Patents

One of his latest patents focuses on the formulation of stabilized cationic transfection agent(s)/nucleic acid particles. This invention concerns a composition that contains stabilized particles of cationic transfection agents and nucleic acid complexes. It is characterized by the inclusion of a non-ionic surfactant in sufficient amounts to prevent the aggregation of the particles over time. In a preferred embodiment, the surfactant is a polyoxyalkylene or a derivative thereof. This innovative approach enhances the stability and efficacy of transfection agents in various applications.

Career Highlights

Bruno Pitard is currently associated with Aventis Pharma S.A., where he continues to advance his research and development efforts. His work at the company has allowed him to explore new frontiers in pharmaceutical sciences, particularly in the area of gene delivery systems.

Collaborations

Throughout his career, Bruno has collaborated with esteemed colleagues such as Joël Crouzet and Gérardo Byk. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Bruno Pitard's contributions to the field of biotechnology, particularly in the development of cationic transfection agents, highlight his role as a significant inventor. His ongoing work promises to impact the future of gene therapy and molecular biology.